Woodline Partners LP G1 Therapeutics, Inc. Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $3 Million - $6.78 Million	1,362,354 New	1,362,354 $3.11 Million
Q2 2023 Aug 14, 2023	SELL	$2.46 - $3.14 $370,075 - $472,372	-150,437 Reduced 50.0%	150,437 $374,000
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $1.87 Million - $5.94 Million	-728,093 Reduced 70.76%	300,874 $806,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $3.9 Million - $10.2 Million	752,067 Added 271.6%	1,028,967 $5.59 Million
Q3 2022 Nov 14, 2022	SELL	$5.17 - $16.99 $7.86 Million - $25.8 Million	-1,520,282 Reduced 84.59%	276,900 $3.46 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $7.26 Million - $15.3 Million	1,797,182 New	1,797,182 $8.88 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.